Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07583862 · ClinicalTrials.gov registry record · Phase 2
The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial
A Phase 2 study, sponsored by Geisinger Clinic.
- Not yet
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT07583862 is a Phase 2 study that has not yet begun recruiting, run by Geisinger Clinic. The registered enrollment target is 40 participants.
The verdict
NCT07583862, a Phase 2 study, has not yet begun recruiting, sponsored by Geisinger Clinic.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this study clinical trial is to learn if topical timolol can accelerate healing and improve the cosmetic appearance of surgical wounds on the scalp following Mohs surgery. It will include Geisinger patients 18 year or older who undergo Mohs surgery of the scalp with planned wound healing by secondary intent. The main questions in aim to answer are: 1. Compare wound healing speed between patients treated with topical timolol and those receiving standard wound care only. 2. Compare cosmetic outcomes using topical timolol and standard wound care. 3. Evaluate the impact of topical timolol on the number of unplanned follow-up visits and calls related to delayed wound healing. Participants will be asked use either topical timolol or use standard wound care to treat their Mohs surgery scalp wound. They will follow-up around 4, 8 and 12 weeks.
Interventions
- DRUG Normal Saline
- DRUG Topical Timolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2029-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07583862
The ClinicalTrials.gov registry entry for NCT07583862 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT07583862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07583862 about?
NCT07583862 is a clinical study titled "The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial". The goal of this study clinical trial is to learn if topical timolol can accelerate healing and improve the cosmetic appearance of surgical wounds on the scalp following Mohs surgery. It will include Geisinger patients 18 year or older who undergo Mohs surgery of the scalp with planned wound healing...
What is the current status of trial NCT07583862?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2026-07-01. Estimated completion is 2029-03.
What interventions are being tested in trial NCT07583862?
The interventions under investigation include: Normal Saline (DRUG), Topical Timolol (DRUG).
Who is sponsoring clinical trial NCT07583862?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.